Drug shortage
Cefotaxime Sodium Powder · Hikma Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Apr 11, 2025
Key facts
| Generic name | Cefotaxime Sodium Powder, for Solution |
|---|---|
| Proprietary name | Cefotaxime Sodium |
| Company | Hikma Pharmaceuticals USA, Inc. |
| Presentation | Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) |
| Dosage form | For Solution, Powder |
| Strength | 500 mg |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Anti-Infective Pediatric |
| Package NDCs | 0143-9930-10 |
| First posted | Feb 17, 2015 |
| Last updated | Apr 11, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: